PRSet: Pathway-based polygenic risk score analyses and software
Shing Wan Choi(Icahn School of Medicine at Mount Sinai), Paul F. O’Reilly(Icahn School of Medicine at Mount Sinai), Yunfeng Ruan(Broad Institute), Clive Hoggart(Icahn School of Medicine at Mount Sinai), Hei Man Wu(Icahn School of Medicine at Mount Sinai), Judit García‐González(Icahn School of Medicine at Mount Sinai), Jessica Johnson(University of North Carolina at Chapel Hill), Christian Porras(Icahn School of Medicine at Mount Sinai)
Cited by 130
Related Papers
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
|Nature|2011|2.1k
De novo mutations in schizophrenia implicate synaptic networks
|Nature|2014|1.7k
Common genetic determinants of vitamin D insufficiency: a genome-wide association study
|The Lancet|2010|1.5k
Gene expression elucidates functional impact of polygenic risk for schizophrenia
|Nature Neuroscience|2016|1.2k
Identification of seven loci affecting mean telomere length and their association with disease
|Nature Genetics|2013|970